REFILE-Lilly's Cyramza meets main goal in gastric cancer study
December 08, 2017 at 18:17 PM EST
Dec 8 (Reuters) - Eli Lilly & Co said on Friday a late-stage trial testing its drug, Cyramza, as a treatment for a type of gastric cancer met its main goal of preventing the disease from advancing.